
|Articles|August 1, 2003
- Pharmaceutical Executive-08-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
The $46 Million Manover 22 years ago
More Than Just a Pretty Faceover 22 years ago
Managing the Innovatorover 22 years ago
Protecting IP Throughout the Product LifecycleNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
4
Pharmaceutical Executive Daily: FDA Approves Breztri
5




